Management of tachycardia
Rakesh Gopinathannair1, Brian Olshansky2
1Division of Cardiovascular Medicine, University of Louisville School of Medicine ACB/A3L41, 550 So. Jackson St., Louisville, KY USA.
F1000Prime Reports
|June 23, 2015
Summary
Persistent tachycardia, a heart rate over 100 beats per minute, can lead to cardiomyopathy. This review covers tachycardia causes, treatments, and outcomes for patients with this heart condition.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure
Background:
- Tachycardia, defined as a heart rate exceeding 100 beats per minute, is a common clinical finding.
- It can stem from various physiological or pathological causes.
- A significant adverse consequence of persistent tachycardia is its association with cardiomyopathy.
Purpose of the Study:
- To provide a comprehensive and up-to-date review of tachycardia.
- To elucidate the etiology of tachycardia.
- To discuss management strategies and prognosis in patients with tachycardia and cardiomyopathy.
Main Methods:
- Literature review of current research on tachycardia and cardiomyopathy.
- Synthesis of information on etiological factors.
- Analysis of established and emerging management strategies.
- Review of prognostic indicators for affected patients.
Main Results:
- Tachycardia is frequently encountered and has diverse origins.
- Persistent tachycardia is a recognized risk factor for developing cardiomyopathy.
- Effective management strategies exist, influencing patient outcomes.
Conclusions:
- Understanding the etiology of tachycardia is crucial for timely intervention.
- Prompt management of tachycardia can mitigate the risk or progression of cardiomyopathy.
- Patients with tachycardia and cardiomyopathy require tailored treatment approaches for optimal prognosis.
Related Concept Videos
01:17Increased pulse rate
1.5K
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.5K
01:25Dysrhythmias VI: Management of Dysrhythmias
633
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
633
01:14Decreased pulse rate
1.1K
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
1.1K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.4K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
547
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
547
01:30Heart Failure V: Medical Management
564
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
564